These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 4152120)

  • 1. Major tranquillizers in the management of psychasthenic neurosis.
    Lax V; Szobor A
    Ther Hung; 1972; 20(4):139-47. PubMed ID: 4152120
    [No Abstract]   [Full Text] [Related]  

  • 2. [Discriminative study of the effect of a psychotropic drug by use of B.P.R.S. cards].
    Sizaret P; Degiovanni A; Penaud J
    Encephale; 1972; 61(4):316-24. PubMed ID: 4145384
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical action of a sedative neuroleptic (cyamepromazine)].
    Singer L; Patris M; Finance F; Meyer R; Eberhardt A; Kammerer C; Marrakchi T
    Ann Med Psychol (Paris); 1973 Nov; 2(4):540-7. PubMed ID: 4151547
    [No Abstract]   [Full Text] [Related]  

  • 5. Piperacetazine in the treatment of mixed neurotics.
    Lapierre YD; Lee M
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):105-9. PubMed ID: 1209
    [No Abstract]   [Full Text] [Related]  

  • 6. A chemotherapeutic alternative to the antianxiety agents for the extended treatment of psychoneurosis.
    Lofft JG; Demars JP
    Dis Nerv Syst; 1974 Sep; 35(9):409-15. PubMed ID: 17894066
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden death in a patient with Tourette syndrome during a clinical trial of ziprasidone.
    Scahill L; Blair J; Leckman JF; Martin A
    J Psychopharmacol; 2005 Mar; 19(2):205-6. PubMed ID: 15728441
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ziprasidone. A new second-generation antipsychotic agent].
    Lublin HK
    Ugeskr Laeger; 2004 Mar; 166(14):1334-9. PubMed ID: 15101124
    [No Abstract]   [Full Text] [Related]  

  • 9. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustaining short-term gains for future progress.
    Cañas F
    Int Clin Psychopharmacol; 2001 Jan; 16 Suppl 1():S9-13. PubMed ID: 11252525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 12. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
    Bentley ML; Biscardi FH; Butcher C; Levitov A
    Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
    [No Abstract]   [Full Text] [Related]  

  • 13. A 6-month prospective, observational, naturalistic, uncontrolled study to evaluate the effectiveness and tolerability of oral ziprasidone in patients with schizophrenia.
    Arango C; Gómez-Beneyto M; Brenlla J; Gastó C; Sarramea-Crespo F; Chamorro L; Masramon X; Díez T;
    Eur Neuropsychopharmacol; 2007; 17(6-7):456-63. PubMed ID: 17234389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on ziprasidone.
    Green B
    Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of ziprasidone: an expanding perspective.
    Daniel DG
    J Clin Psychiatry; 2003; 64 Suppl 19():40-9. PubMed ID: 14728089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of young people with atypical antipsychotic agents].
    Stenstrøm AD; Jensen PN
    Ugeskr Laeger; 2003 Jun; 165(23):2411; author reply 2411-2. PubMed ID: 12841004
    [No Abstract]   [Full Text] [Related]  

  • 18. Naturalistic study of intramuscular ziprasidone versus conventional agents in agitated elderly patients: retrospective findings from a psychiatric emergency service.
    Kohen I; Preval H; Southard R; Francis A
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):240-5. PubMed ID: 16503319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New technic of controlled psychoautonomic shock (apomorphine-metaclopramide)].
    Albaladejo Herrero A
    Actas Luso Esp Neurol Psiquiatr; 1968 Jan; 27(1):22-9. PubMed ID: 5740586
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term use of 200 mg Dogmatil. Apropos of 13 cases].
    Planche R
    Sem Hop; 1984 Mar; 60(13):944-8. PubMed ID: 6144185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.